Department of Veterans Affairs Awarded a Contract to POLYMEDCO LLC for $126,274.50

Summary of Award

The United States Department of Veterans Affairs (VA) has engaged in a significant contract with POLYMEDCO LLC, a company based in Cortlandt Manor, New York. The agreement, executed under the contract identifier "36C24624N0302," involves the provision of automated fecal occult blood analyzers and supplies. This contract is categorized as a Blanket Purchase Agreement Call (BPA CALL) with a total obligated value of $126,274.50.

### Background and Context

This contract falls under the purview of the Department of Veterans Affairs, specifically managed by the Veterans Health Administration through the 246-Network Contracting Office 6. It represents a fixed commitment to provide vital laboratory equipment, specifically designed to facilitate fecal occult blood tests, which are crucial for the early detection of colorectal cancer. ### Contract Details The contract is described as "FIRM FIXED PRICE," meaning the price is fixed and not subject to change regardless of the resources or time spent by POLYMEDCO LLC in fulfilling its obligations. This pricing structure is beneficial for the government as it provides cost certainty and minimizes potential financial risk. The performance period for this contract spans from December 1, 2023, to November 30, 2024. This duration underscores the contract’s operational framework, allowing the VA ample time and resources to utilize the supplied analyzers and ensure the services fulfill the required expectations. ### Recipient Insights POLYMEDCO LLC, the contract recipient, is a recognized entity within the analytical laboratory instrument manufacturing industry, as evidenced by its registration under NAICS code "334516." The company operates out of New York, categorized as a small, U.S.-owned business. This designation suggests that the VA is supportive of small businesses, contributing to economic growth by engaging domestic enterprises for federal contracts. The company's primary business line involves manufacturing laboratory instruments, which aligns with its current contract obligations to supply automated analyzers. Their expertise and specialization in laboratory equipment foster confidence that they can deliver products meeting stringent federal standards pertinent to veterans’ healthcare needs. ### Transactional Analysis The transactions associated with this agreement highlight two significant financial activities: 1. **Initial Transaction (December 1, 2023):** - A transaction on the date the contract began reveals an initial obligation of $126,274.50 from the VA to POLYMEDCO LLC. This action signified the formal commencement of the contractual relationship and the federal government's financial commitment upon issuance of the BPA CALL. 2. **Subsequent Modification (April 10, 2025):** - A subsequent transaction on April 10, 2025, reflects a negative transaction amount of -$38,782.31. This indicates a reduction or modification, possibly related to adjustments in the contract requirements or reconciliations based on deliverables received and evaluated by the VA. Such adjustments often occur in federal contracting to reflect actual needs and resource utilization, showcasing the dynamic nature of government settlements. ### Procedural and Competitive Aspects The contract underwent a competitive process, falling under the "FULL AND OPEN COMPETITION" category. Such a process ensures that the government receives fair market prices and quality standards while promoting transparency and accountability. The "MULTIPLE AWARD FAIR OPPORTUNITY (MAFO)" procedures guarantee that the choice of POLYMEDCO LLC was predicated on objective evaluation against other potential contractors. ### Relevance and Implications The objective of acquiring these specific laboratory instruments is straightforward: enhancing medical diagnostic capabilities within veterans' health services. The analyzers are pivotal for detecting occult blood in stool samples, a key marker in identifying colorectal diseases early. This equipment's deployment fits into broader VA goals of improving healthcare outcomes for veterans, potentially saving lives through prompt and early healthcare interventions. Moreover, engaging POLYMEDCO LLC reflects a degree of trust in their operational competency and product reliability. By supporting a small business, the VA contributes directly to local economies and encourages innovation within the specialized field of medical diagnostic equipment. ### Conclusion This contract review reveals the Department of Veterans Affairs' strategic approach to contracting, emphasizing fiscal responsibility, competitive procurement practices, and comprehensive support for veterans' healthcare needs. POLYMEDCO LLC, with its established credentials in laboratory instruments, stands poised to meet these demands, ensuring the efficient and effective utility of public funds. As the contract progresses and future evaluations and modifications are considered, continuous oversight will be essential. This ensures sustained compliance with contractual obligations and alignment with the evolving demands of veteran healthcare services. The ongoing collaboration between POLYMEDCO LLC and the VA mirrors a broader commitment to healthcare excellence and public accountability, encapsulating the intricacies, and responsibilities inherent in federal procurement processes.